Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Allan Tobi
Observed name:
Tobi, Allan
Institution:
University of Tartu
Observed institution:
University of Tartu
ORCID:
0000-0003-4797-5481
Observed ORCID:
0000-0003-4797-5481
OpenAlex ID:
A5001257443
Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity
2020
·
Ludovico Cantuti-Castelvetri
, Ravi Ojha
, et al.
·
Science
·
2,064
PDF
Precision Targeting of Tumor Macrophages with a CD206 Binding Peptide
2017
·
Pablo Scodeller
, Lorena Simón-Gracia
, et al.
·
Scientific Reports
·
198
PDF
Peptide-guided nanoparticles for glioblastoma targeting
2019
·
Pille Säälik
, Prakash Lingasamy
, et al.
·
Journal of Controlled Release
·
111
PDF
Tumor-Penetrating Nanosystem Strongly Suppresses Breast Tumor Growth
2017
·
Shweta Sharma
, Venkata Ramana Kotamraju
, et al.
·
Nano Letters
·
104
Tumor-penetrating peptide for systemic targeting of Tenascin-C
2020
·
Prakash Lingasamy
, Allan Tobi
, et al.
·
Scientific Reports
·
79
PDF
Targeting of p32 in peritoneal carcinomatosis with intraperitoneal linTT1 peptide-guided pro-apoptotic nanoparticles
2017
·
Hedi Hunt
, Lorena Simón-Gracia
, et al.
·
Journal of Controlled Release
·
77
Bi-specific tenascin-C and fibronectin targeted peptide for solid tumor delivery
2019
·
Prakash Lingasamy
, Allan Tobi
, et al.
·
Biomaterials
·
72
PDF
In vivo phage display: identification of organ-specific peptides using deep sequencing and differential profiling across tissues
2021
·
Karlis Pleiko
, Kristina Põšnograjeva
, et al.
·
Nucleic Acids Research
·
60
PDF
Exposed CendR Domain in Homing Peptide Yields Skin-Targeted Therapeutic in Epidermolysis Bullosa
2020
·
Toini Pemmari
, Larisa Ivanova
, et al.
·
Molecular Therapy
·
30
PDF
Peptide-targeted nanoparticles for tumor therapy
2025
·
Valeria Sidorenko
, Allan Tobi
, et al.
·
Journal of Controlled Release
·
28
ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1
2022
·
Boris Simonetti
, James L. Daly
, et al.
·
Proceedings of the National Academy of Sciences
·
28
Homing Peptide-Based Targeting of Tenascin-C and Fibronectin in Endometriosis
2021
·
Lorena Simón-Gracia
, Kristina Kiisholts
, et al.
·
Nanomaterials
·
25
PDF
Silver Nanocarriers Targeted with a CendR Peptide Potentiate the Cytotoxic Activity of an Anticancer Drug
2020
·
Allan Tobi
, Anne‐Mari A. Willmore
, et al.
·
Advanced Therapeutics
·
23
PDF
PL1 Peptide Engages Acidic Surfaces on Tumor-Associated Fibronectin and Tenascin Isoforms to Trigger Cellular Uptake
2021
·
Prakash Lingasamy
, Kristina Põšnograjeva
, et al.
·
Pharmaceutics
·
22
PDF
Ratiometric in vivo auditioning of targeted silver nanoparticles
2017
·
Kadri Toome
, Anne-Mari A. Willmore
, et al.
·
Nanoscale
·
22
Protease-activated CendR peptides targeting tenascin-C: mitigating off-target tissue accumulation
2024
·
Allan Tobi
, Maarja Haugas
, et al.
·
Drug Delivery and Translational Research
·
9
Targeting oncofetal fibronectin and neuropilin-1 in solid tumors with PL2 peptide
2025
·
Prakash Lingasamy
, Allan Tobi
, et al.
·
Scientific Reports
·
8
PDF
Abstract LB-062: Targeting of p32 in peritoneal carcinomatosis with intraperitoneal linTT1 peptide-guided pro-apoptotic nanoparticles
2017
·
Tambet Teesalu
, Hunt Hedi
, et al.
·
Cancer Research
Abstract 1343: P32-targeting TT1 peptide delivers nanoparticles to intracranial glioblastomas
2016
·
Pille Säälik
, Hedi Hunt
, et al.
·
Cancer Research
Abstract 2164: Tenascin-C binding peptides for cancer targeting
2016
·
Prakash Lingasamy
, Allan Tobi
, et al.
·
Cancer Research
Show more works
View as search
Works count:
22
Citation count:
2,960
H-index:
15
I10-index:
15
Year
Topic
Type